Mark A. Levy

4.8k total citations
100 papers, 3.4k citations indexed

About

Mark A. Levy is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Mark A. Levy has authored 100 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 19 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Genetics. Recurrent topics in Mark A. Levy's work include Hormonal and reproductive studies (15 papers), Hormonal Regulation and Hypertension (13 papers) and Estrogen and related hormone effects (12 papers). Mark A. Levy is often cited by papers focused on Hormonal and reproductive studies (15 papers), Hormonal Regulation and Hypertension (13 papers) and Estrogen and related hormone effects (12 papers). Mark A. Levy collaborates with scholars based in United States, United Kingdom and Canada. Mark A. Levy's co-authors include Dennis A. Holt, Martín Brandt, Richard B. Silverman, Brian W. Metcalf, Mary J. Bossard, Derk J. Bergsma, Paul L. Koser, Randall K. Johnson, Thaddeus A. Tomaszek and Scott K. Thompson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Mark A. Levy

99 papers receiving 3.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark A. Levy 2.0k 644 449 419 324 100 3.4k
Saburo Onishi 1.9k 1.0× 779 1.2× 601 1.3× 597 1.4× 217 0.7× 196 5.1k
Jean‐Claude Mazière 1.8k 0.9× 351 0.5× 350 0.8× 256 0.6× 618 1.9× 142 4.1k
John J. McGuire 1.9k 0.9× 601 0.9× 1.1k 2.4× 140 0.3× 244 0.8× 176 4.9k
Mushtaq Ahmad 1.3k 0.7× 298 0.5× 341 0.8× 184 0.4× 319 1.0× 67 3.3k
Alfred Gallegos 2.2k 1.1× 471 0.7× 249 0.6× 191 0.5× 222 0.7× 34 3.1k
Huy Ong 2.0k 1.0× 401 0.6× 339 0.8× 528 1.3× 215 0.7× 140 4.4k
Huiwen Zhang 1.2k 0.6× 269 0.4× 316 0.7× 539 1.3× 240 0.7× 258 3.2k
Katsuhiko Ono 1.4k 0.7× 342 0.5× 210 0.5× 184 0.4× 229 0.7× 103 3.4k
Jules A. Shafer 2.9k 1.5× 600 0.9× 684 1.5× 329 0.8× 445 1.4× 130 6.0k
Anthony M. Treston 1.3k 0.7× 532 0.8× 273 0.6× 348 0.8× 371 1.1× 79 2.6k

Countries citing papers authored by Mark A. Levy

Since Specialization
Citations

This map shows the geographic impact of Mark A. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Levy more than expected).

Fields of papers citing papers by Mark A. Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Levy. The network helps show where Mark A. Levy may publish in the future.

Co-authorship network of co-authors of Mark A. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Levy. A scholar is included among the top collaborators of Mark A. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Levy. Mark A. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pothuri, Bhavana, et al.. (2024). 735P HRD signature (HRDsig) in endometrial cancer (EC). Annals of Oncology. 35. S559–S559. 1 indexed citations
2.
Wang, Jun, Jinli Chen, Ira M. Bernstein, et al.. (2021). β -Glucan Improves Protective Qi Status in Adults with Protective Qi Deficiency—A Randomized, Placebo-Controlled, and Double-Blinded Trial. Chinese Journal of Integrative Medicine. 28(5). 394–402. 2 indexed citations
3.
Bernstein, Ira M., et al.. (2020). Development and validation of a diagnostic risk score for assessing a TCM condition, Protective Qi Deficiency, in adults. European Journal of Integrative Medicine. 35. 101097–101097. 1 indexed citations
4.
Jin, Huifeng, Wei Chen, Xiaoming Sheng, et al.. (2018). An evidence-based approach to globally assess the covariate-dependent effect of the MTHFR single nucleotide polymorphism rs1801133 on blood homocysteine: a systematic review and meta-analysis. American Journal of Clinical Nutrition. 107(5). 817–825. 18 indexed citations
5.
Lim, Yunsook, Mark A. Levy, & Tammy Μ. Bray. (2004). Dietary Zinc Alters Early Inflammatory Responses during Cutaneous Wound Healing in Weanling CD-1 Mice. Journal of Nutrition. 134(4). 811–816. 58 indexed citations
6.
Ward, Katie, Joel W. Proksch, Peter D. Gorycki, et al.. (2002). SB-242235, a selective inhibitor of p38 mitogen-activated protein kinase. II: In vitro and in vivo metabolism studies and pharmacokinetic extrapolation to man. Xenobiotica. 32(3). 235–250. 11 indexed citations
7.
Ward, Katie, Joel W. Proksch, Kevin L. Salyers, et al.. (2002). SB-242235, a selective inhibitor of p38 mitogenactivated protein kinase. I: Preclinical pharmacokinetics. Xenobiotica. 32(3). 221–233. 11 indexed citations
8.
Nuttall, Mark, Daniel P. Nadeau, Paul W. Fisher, et al.. (2000). Inhibition of caspase‐3‐like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro. Journal of Orthopaedic Research®. 18(3). 356–363. 79 indexed citations
9.
Morley, Paul S., Thomas E. Wittum, Tammy Μ. Bray, et al.. (1999). Synergistic effects of concurrent challenge with bovine respiratory syncytial virus and 3-methylindole in calves. American Journal of Veterinary Research. 60(5). 563–570. 15 indexed citations
10.
Lee, Dennis, Jerry L. Adams, Martín Brandt, et al.. (1999). A substrate combinatorial array for caspases. Bioorganic & Medicinal Chemistry Letters. 9(12). 1667–1672. 8 indexed citations
11.
Bossard, Mary J., Thaddeus A. Tomaszek, Scott K. Thompson, et al.. (1996). Proteolytic Activity of Human Osteoclast Cathepsin K. Journal of Biological Chemistry. 271(21). 12517–12524. 404 indexed citations
12.
Koser, Paul L., Wai-Kwong Eng, Mary J. Bossard, et al.. (1993). The tyrosine89 residue of yeast FKBP12 is required for rapamycin binding. Gene. 129(2). 159–165. 28 indexed citations
13.
McLaughlin, Megan M., Mary J. Bossard, Paul L. Koser, et al.. (1992). The yeast cyclophilin multigene family: purification, cloning and characterization of a new isoform. Gene. 111(1). 85–92. 34 indexed citations
14.
Isaacs, John T., et al.. (1992). Response of rat and human prostatic cancers to the novel 5α‐reductase inhibitor, SK&F 105657. The Prostate. 21(1). 15–34. 57 indexed citations
15.
Koltin, Y., Leo F. Faucette, Derk J. Bergsma, et al.. (1991). Rapamycin Sensitivity in Saccharomyces cerevisiae Is Mediated by a Peptidyl-Prolyl cis-trans Isomerase Related to Human FK506-Binding Protein. Molecular and Cellular Biology. 11(3). 1718–1723. 188 indexed citations
16.
Holt, Dennis A., Hye-Ja Oh, Mark A. Levy, & Brian W. Metcalf. (1991). Synthesis of a steroidal A ring aromatic sulfonic acid as an inhibitor of steroid Sa-reductase. Steroids. 56(1). 4–7. 9 indexed citations
17.
Koser, Paul L., Derk J. Bergsma, Robert Cafferkey, et al.. (1991). The CYP2 gene of Saccharomyces cerevisiae encodes a cyclosporin A-sensitive peptidyl-prolyl cis-trans isomerase with an N-terminal signal sequence. Gene. 108(1). 73–80. 32 indexed citations
18.
Brandt, Martín, et al.. (1990). Studies on the mechanism of steroid 5α-reductase inhibition by 3-carboxy A-ring aryl steroids. The Journal of Steroid Biochemistry and Molecular Biology. 37(4). 575–579. 10 indexed citations
19.
Levy, Mark A., et al.. (1989). Inhibition and time-dependent inactivation of human placental aromatase by 3-oxo-17β-carboxamido steroids. Journal of Steroid Biochemistry. 33(4). 573–579. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saburo Onishi Breakdown of academic impact, for papers by Jean‐Claude Mazière Breakdown of academic impact, for papers by John J. McGuire Breakdown of academic impact, for papers by Mushtaq Ahmad Breakdown of academic impact, for papers by Alfred Gallegos Breakdown of academic impact, for papers by Huy Ong Breakdown of academic impact, for papers by Huiwen Zhang Breakdown of academic impact, for papers by Katsuhiko Ono Breakdown of academic impact, for papers by Jules A. Shafer Breakdown of academic impact, for papers by Anthony M. Treston
Rankless by CCL
2026